These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 9337539

  • 1. Activity and tissue localization of cathepsin D in non small cell lung cancer.
    Chyczewski L, Płoński A, Chyczewska E, Furman M, Ostrowska H, Nikliński J, Kozłowski M.
    Rocz Akad Med Bialymst; 1997; 42 Suppl 1():217-29. PubMed ID: 9337539
    [Abstract] [Full Text] [Related]

  • 2. Activity and tissue localization of cathepsin G in non small cell lung cancer.
    Maksimowicz T, Chyczewska E, Chyczewski L, Nikliński J, Ostrowska H, Szyszko J, Furman M.
    Rocz Akad Med Bialymst; 1997; 42 Suppl 1():199-216. PubMed ID: 9337538
    [Abstract] [Full Text] [Related]

  • 3. Immunochemical analysis of cathepsin B in lung tumours: an independent prognostic factor for squamous cell carcinoma patients.
    Werle B, Lötterle H, Schanzenbächer U, Lah TT, Kalman E, Kayser K, Bülzebruck H, Schirren J, Krasovec M, Kos J, Spiess E.
    Br J Cancer; 1999 Oct; 81(3):510-9. PubMed ID: 10507778
    [Abstract] [Full Text] [Related]

  • 4. Cathepsin B in infiltrated lymph nodes is of prognostic significance for patients with nonsmall cell lung carcinoma.
    Werle B, Kraft C, Lah TT, Kos J, Schanzenbächer U, Kayser K, Ebert W, Spiess E.
    Cancer; 2000 Dec 01; 89(11):2282-91. PubMed ID: 11147599
    [Abstract] [Full Text] [Related]

  • 5. Immunohistochemical analysis of tissue localization of cytokeratin 19 in lung cancer.
    Chyczewski L, Nikliński J, Chyczewska E, Laudański J, Furman M.
    Rocz Akad Med Bialymst; 1997 Dec 01; 42 Suppl 1():162-72. PubMed ID: 9337534
    [Abstract] [Full Text] [Related]

  • 6. Studies on angiogenesis intensity in lung cancer in aspect of its correlation with histological type of tumor and clinical stage.
    Juczewska M, Chyczewski L, Telego M, Chyczewska E, Nikliński J, Tańska M, Laudański J.
    Rocz Akad Med Bialymst; 1997 Dec 01; 42 Suppl 1():254-70. PubMed ID: 9337543
    [Abstract] [Full Text] [Related]

  • 7. Association between cyclooxygenase-2 and matrix metalloproteinase-2 expression in non-small cell lung cancer.
    Byun JH, Lee MA, Roh SY, Shim BY, Hong SH, Ko YH, Ko SJ, Woo IS, Kang JH, Hong YS, Lee KS, Lee AW, Park GS, Lee KY.
    Jpn J Clin Oncol; 2006 May 01; 36(5):263-8. PubMed ID: 16735371
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Expression and prognostic relation of cathepsin D in non-small cell lung cancer tissues and lymph nodes].
    Wang Z, Zhao X.
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Mar 01; 21(3):164-6. PubMed ID: 11263354
    [Abstract] [Full Text] [Related]

  • 10. Increased cathepsin B activity in human lung tumors.
    Krepela E, Kasafírek E, Novák K, Viklický J.
    Neoplasma; 1990 Mar 01; 37(1):61-70. PubMed ID: 2320181
    [Abstract] [Full Text] [Related]

  • 11. Topoisomerase IIalpha gene expression is regulated by the p53 tumor suppressor gene in nonsmall cell lung carcinoma patients.
    Liu D, Huang CL, Kameyama K, Hayashi E, Yamauchi A, Sumitomo S, Yokomise H.
    Cancer; 2002 Apr 15; 94(8):2239-47. PubMed ID: 12001123
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Epidermal growth factor receptor, cyclooxygenase-2, and BAX expression in the primary non-small cell lung cancer and brain metastases.
    Milas I, Komaki R, Hachiya T, Bubb RS, Ro JY, Langford L, Sawaya R, Putnam JB, Allen P, Cox JD, McDonnell TJ, Brock W, Hong WK, Roth JA, Milas L.
    Clin Cancer Res; 2003 Mar 15; 9(3):1070-6. PubMed ID: 12631609
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Telomerase activity as a prognostic indicator in stage I non-small cell lung cancer.
    Marchetti A, Bertacca G, Buttitta F, Chella A, Quattrocolo G, Angeletti CA, Bevilacqua G.
    Clin Cancer Res; 1999 Aug 15; 5(8):2077-81. PubMed ID: 10473089
    [Abstract] [Full Text] [Related]

  • 17. Up-regulation of proline-rich tyrosine kinase 2 in non-small cell lung cancer.
    Zhang S, Qiu X, Gu Y, Wang E.
    Lung Cancer; 2008 Dec 15; 62(3):295-301. PubMed ID: 18571765
    [Abstract] [Full Text] [Related]

  • 18. Border between N1 and N2 stations in lung carcinoma: lessons from lymph node metastatic patterns of lower lobe tumors.
    Okada M, Sakamoto T, Yuki T, Mimura T, Nitanda H, Miyoshi K, Tsubota N.
    J Thorac Cardiovasc Surg; 2005 Apr 15; 129(4):825-30. PubMed ID: 15821650
    [Abstract] [Full Text] [Related]

  • 19. Activity of some lysosomal enzymes in serum and in tumors of patients with squamous cell lung carcinoma.
    Woźniak A, Drewa T, Rozwodowska M, Drewa G, Lambrecht W, Wiśniewska I.
    Neoplasma; 2002 Apr 15; 49(1):10-5. PubMed ID: 12044053
    [Abstract] [Full Text] [Related]

  • 20. Expression of MDA-7/IL-24 and its clinical significance in resected non-small cell lung cancer.
    Ishikawa S, Nakagawa T, Miyahara R, Kawano Y, Takenaka K, Yanagihara K, Otake Y, Katakura H, Wada H, Tanaka F.
    Clin Cancer Res; 2005 Feb 01; 11(3):1198-202. PubMed ID: 15709189
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.